People · Operator

G. Douglas Smith

Named in public records as an officer, director or promoter · active 2010–2022 · Other Health Care, Other

2
Companies
4
Filings
$7.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Vital Access CorpOther Health CareSeed$6.9M$37.2M2010
41 Chestnut LLCOtherPre-Seed$950K$9.5M2022
Operator network

G. Douglas Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Richard J. Linder · 3 companies · 1 sharedRichard J. LinderDavid B. Berger · 2 companies · 1 sharedDavid B. BergerDavid D. Hochman · 1 companies · 1 sharedDavid D. HochmanDuane D. Blatter · 1 companies · 1 sharedDuane D. BlatterYuval B. Binur · 1 companies · 1 sharedYuval B. BinurYuval D. Binur · 1 companies · 1 sharedYuval D. BinurBen Cote · 1 companies · 1 sharedBen CoteBrian Sprague · 1 companies · 1 sharedBrian SpragueDavid Holman · 1 companies · 1 sharedDavid HolmanErin Mangalam · 1 companies · 1 sharedErin MangalamJean Burr · 1 companies · 1 sharedJean BurrKacy Douglas Hintze · 1 companies · 1 sharedKacy Douglas Hint…Michael Thyssen · 1 companies · 1 sharedMichael ThyssenVital Access Corp · $6.9M raisedVital Access Corp41 Chestnut LLC · $0.9M raised41 Chestnut LLCG. Douglas SmithGS
G. Douglas Smith Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside G. Douglas Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Richard J. Linder13
David B. Berger12
Yuval B. Binur11
David D. Hochman11
Duane D. Blatter11
Brian Sprague11
David Holman11
Michael Thyssen11
Erin Mangalam11
Jean Burr11
Kacy Douglas Hintze11
Ben Cote11
Yuval D. Binur11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.